FDA approves Wockhardt enlarged prostate drug

Alfuzosin hydrochloride approved

PARSIPPANY, N.J. — The Food and Drug Administration has approved a drug for enlarged prostate made by generic drug maker Wockhardt, the company said.

Wockhardt, based in Mumbai, India, announced the approval of alfuzosin hydrochloride extended-release tablets in the 10-mg strength, which is designed to treat enlarged prostate, also known as benign prostatic hyperplasia.

The drug is a generic version of Sanofi's Uroxatral. Various versions of the drug have sales of about $81.5 million, according to IMS Health.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

Comments

- 12:57 AM
smithjohnn says

Wockhardt is reowned company and there are many other company like herbal life which promote Ageless Male - Does Ageless Male Work. As I have read some reviews for its side effects.

Login or Register to post a comment.